Patents
Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
11/2001
11/14/2001EP1153029A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/13/2001US6316432 Antigestagenically active steroids with a flourinated 17 α-alkyl chain
11/13/2001US6316422 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
11/08/2001WO2001083512A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
11/08/2001US20010039268 New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
11/08/2001CA2418748A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
11/07/2001EP1150993A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
10/2001
10/31/2001EP0888380B1 Process for alkylating and smiles rearrangement of hydroxy aromatics
10/31/2001EP0837070B1 Sialic acid derivatives
10/30/2001US6310052 Nitrate esters and their use for neurological conditions
10/25/2001WO2001079255A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
10/24/2001EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein
10/24/2001EP1147124A2 Steroid sulfatase inhibitors and methods for making and using the same
10/23/2001US6307074 Process for the preparation of bile acid derivatives
10/18/2001WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
10/18/2001WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES
10/18/2001WO2001076531A2 Bile acid containing prodrugs with enhanced bioavailability
10/18/2001DE10019167A1 New 8 beta-substituted 11 beta-(pentyl or hexyl)-estra-1,3,5(10)-triene derivatives, are ovary-selective estrogen receptor ligands useful e.g. as female or male contraceptives or for treating ovarian carcinoma
10/18/2001CA2405151A1 Bile acid containing prodrugs with enhanced bioavailability
10/17/2001EP1144432A1 Steroid derived antibiotics
10/17/2001EP1144431A2 16-hydroxyestratrienes as selective estrogens
10/11/2001WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents
10/11/2001WO2001074761A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/11/2001WO2000042058A9 Steroid derived antibiotics
10/11/2001CA2404628A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/10/2001EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
10/04/2001WO2001072767A1 Dehydroepiandrosterone derivatives, preparation method and uses thereof, in particular for cosmetics
10/02/2001US6297228 Use of angiostatic steroids in photodynamic therapy
09/2001
09/26/2001EP1135403A1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
09/20/2001WO2001018025A3 17alpha propynyl 11-aryl steroids
09/19/2001EP0728140B1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
09/19/2001CN1313862A Novel 17-halogenated 19-Nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
09/11/2001US6288051 Estrogen-dependent breast cancer treatment
09/11/2001US6288050 Steroid sulfatase inhibitors and methods for making and using the same
09/11/2001US6288041 Sialic acid derivatives
09/07/2001WO2001064708A1 Bile acids conjugates with metal ion chelates and the use thereof
09/07/2001WO2001014406A8 Antiandrogen agents
09/07/2001WO2000047603A9 16-hydroxyestratrienes as selective estrogens
09/04/2001US6284887 Process for preparing carboxamido-4-azasteroids
08/2001
08/30/2001US20010018435 Prohormones; chemical intermediate in steroid metabolism in humans
08/28/2001US6281376 Therapeutic compound—fatty acid conjugates
08/28/2001US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
08/28/2001US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions
08/22/2001EP1124841A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them
08/21/2001US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
08/14/2001US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
08/09/2001WO2001057064A2 Cationic amphiphiles for use in nucleic acid transfection
08/07/2001US6271403 7α-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents
08/02/2001WO2001055098A1 Palatable arginine compounds and uses thereof for cardiovascular health
08/02/2001WO2000047603A3 16-hydroxyestratrienes as selective estrogens
08/02/2001EP1144431A3 16-hydroxyestratrienes as selective estrogens
08/02/2001CA2395447A1 Palatable arginine compounds and uses thereof for cardiovascular health
07/2001
07/31/2001US6268516 Cationic amphiphilic lipids for liposomal gene transfer
07/26/2001WO2001053355A1 An in vivo screen using chemical inducers of dimerization
07/26/2001WO2001016157A3 A process for the preparation of 3-amino bile acid derivatives
07/26/2001CA2398010A1 An in vivo screen using chemical inducers of dimerization
07/19/2001WO2001006261A3 Screening for therapeutic agents being scap antagonists
07/19/2001US20010008941 Treating osteoporosis; having no endometrial hyperplasia activity nor breast tumor proliferation activity
07/19/2001DE19961219A1 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 11beta-Phenylestratrien derivatives with fluoroalkyl groups in the aromatic side chain, their preparation and pharmaceutical compositions containing them
07/18/2001EP0721446B1 Chiral surfactants and methods for their use in chiral separations
07/17/2001US6262283 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
07/17/2001US6262043 Show inhibitory activity against steroid sulfatase and are useful in treating or preventing hormone dependent diseases.
07/17/2001US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/17/2001CA2130515C New 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethylestradiene derivatives, methods for their production and pharmaceuticals containing these substances
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/11/2001CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/10/2001US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment
07/05/2001WO2001047945A1 Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
07/05/2001US20010006946 Improved gene transfer efficiency by coadministering with a cholic acid or deoxycholic acid amide derivative of given formula
07/03/2001CA2023012C 4-substituted 17.beta.-(cyclopropylamino)androst-5-en-3.beta.-ol and related compounds useful as c17-20 lyase inhibitors
06/2001
06/28/2001WO2001045678A2 Medicament, a method for its production and the use thereof
06/28/2001US20010005756 New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
06/26/2001US6251939 Carbamate-based cationic lipids
06/21/2001WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
06/21/2001WO2001044267A1 11-β-PHENYLESTRADIENE DERIVATIVES WITH FLUOROALKYL GROUPS IN THE AROMATIC SIDE CHAIN, PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
06/19/2001US6248352 Compositions containing lipid compounds derived from sphingoid bases, their process of preparation
06/14/2001WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/14/2001US20010003782 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells
06/13/2001EP1105730A1 Enzyme inhibition immunoassay
06/13/2001EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
06/13/2001EP1105407A2 Aminosterol compounds and uses thereof
06/07/2001WO2001040805A1 Steroid compounds for steroid receptor binding assays
06/07/2001WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases
06/07/2001WO2001018028A8 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase
06/07/2001CA2391096A1 3-methylene steroid derivatives
06/05/2001US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function
05/2001
05/29/2001US6239121 4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
05/23/2001CN1296492A Fatty acid derivatives of bile acids and bile acid derivatives
05/16/2001EP1099706A2 Estrane sulphamate derivatives as steroid sulphatase inhibitors
05/10/2001WO2001032680A2 18-nor-steroids as selectively active estrogens
05/10/2001WO2001000652A3 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
05/09/2001CN1294514A Steroid derived antibiotics
05/08/2001US6229029 11β-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicaments
05/02/2001EP1094798A2 INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
04/2001
04/25/2001CN1292797A Cholenic acid amides and pharmaceutical compositions thereof
04/18/2001EP0796240B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
04/18/2001CN1291990A S-Substituted 11 & Beta-Benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for production thereof and pharmaceutical preparations containing these compounds
04/11/2001EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
04/11/2001CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 47